/Investor DB

Meritech Capital Partners — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

10x Genomics10xgenomics.comin𝕏NASDAQ: TXGMay 2019 · $50M

10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.

BiotechDeep TechHardwareHealthtechPleasanton, US

Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)inJean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)in

Co-investorsFoothill VenturesForesite CapitalKhosla VenturesOMX VenturesPaladin Capital GroupSoftBank Vision Fund+4 more

Filevinefilevine.comin𝕏Nov 2019

Filevine provides case management, document management, client communication, contract lifecycle management, and business analytics software for law firms and legal organizations.

AI & Machine LearningEnterprise SoftwareLegalTechSaaSLas Vegas, US

Ryan Anderson(Founder)inNathan Morris(Founder)inJim Blake(Founder)Nate Morris(Founder)

BoardJeff Cooper(Director)Jonathan Ord(Director)

Board seatPaul Madera· per SEC Form D

Co-investorsCross Creek AdvisorsGolub GrowthRun VenturesAccelAlbum VCInsight Partners+3 more

Segmentsegment.com𝕏Late Stage · Apr 2019 · $180Macquired by Twilio

Segment is a customer data platform that collects, unifies, and activates first-party customer data from multiple touchpoints, enabling businesses to create unified customer profiles and orchestrate personalized experiences across 750+ integrations and destinations.

Data & InfrastructureEnterprise SoftwareMarketing TechSaaSSan Francisco, US

Ilya Volodarsky(Founder)inCalvin French-Owen(CTO)Peter Reinhardt(CEO)inIan Taylor(Cofounder)inJenn Garrett(Executive Officer)Andrew Beaird(Executive Officer)

Co-investorsAccelConvergeFounders Circle CapitalGreycroftGV (Google Ventures)Headline+13 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.